Literature DB >> 15340890

[Stromal cell transplant in the 6-OHDA lesion model].

N Pavón-Fuentes1, L Blanco-Lezcano, L Martínez-Martín, L Castillo-Díaz, K de la Cuétara-Bernal, R García-Miniet, L Lorigados-Pedre, Y Coro-Grave de Peralta, A Y García-Varona, J C Rosillo-Martí, R Macías-González.   

Abstract

INTRODUCTION: A good deal of evidence currently exists to show that transplanting foetal mesencephalic tissue can produce symptomatic benefits both in patients and in disease models. Nevertheless, the technical and ethical difficulties involved in obtaining enough suitable foetal cerebral tissue have been a serious obstacle to its application. Stromal cells derived from bone marrow, due to their potential capacity to generate different types of cells, could be an ideal source of material for cell restoration in neurodegenerative diseases. AIMS: Our aim was to evaluate the effect of transplanting stromal cells derived from bone marrow on the behaviour of 6-OHDA rats, when they are inserted into the striatum.
MATERIAL AND METHODS: In this study we used rats with a lesion in the substantia nigra induced by 6-hydroxydopamine, divided into several experimental groups. Rotary activity induced by D-amphetamine (5 mg/kg, intraperitoneally) was evaluated before and throughout the three months following the transplant in all the experimental groups, except in the group of healthy controls. Hemiparkinsonian rats received a total of 350 000 foetal ventral mesencephalic cells and 8 x 10(4) stromal cells/microL, which were implanted in the striatum. RESULTS AND
CONCLUSIONS: Animals with stromal cells transplanted in the body of the striatum significantly reduced the number of turns induced by amphetamine (p < 0.05); yet this reduction was not greater than that induced by foetal mesencephalic cell transplants. We were also unable to demonstrate any significant improvement in the motor skills of the forelimbs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340890

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  3 in total

1.  KM-34, a Novel Antioxidant Compound, Protects against 6-Hydroxydopamine-Induced Mitochondrial Damage and Neurotoxicity.

Authors:  Luis Arturo Fonseca-Fonseca; Yanier Nuñez-Figueredo; Jeney Ramírez Sánchez; Maylin Wong Guerra; Estael Ochoa-Rodríguez; Yamila Verdecia-Reyes; René Delgado Hernádez; Noelio J Menezes-Filho; Teresa Cristina Silva Costa; Wagno Alcântara de Santana; Joana L Oliveira; Juan Segura-Aguilar; Victor Diogenes Amaral da Silva; Silva Lima Costa
Journal:  Neurotox Res       Date:  2018-01-02       Impact factor: 3.911

2.  Intrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian rats.

Authors:  Janine Müller; Christiana Ossig; Johannes F W Greiner; Stefan Hauser; Mareike Fauser; Darius Widera; Christian Kaltschmidt; Alexander Storch; Barbara Kaltschmidt
Journal:  Stem Cells Transl Med       Date:  2014-12-05       Impact factor: 6.940

3.  Intracerebroventricular transplanted bone marrow stem cells survive and migrate into the brain of rats with Parkinson's disease.

Authors:  Ping Gu; Zhongxia Zhang; Dongsheng Cui; Yanyong Wang; Lin Ma; Yuan Geng; Mingwei Wang
Journal:  Neural Regen Res       Date:  2012-05-05       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.